Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

There are numerous observations confirming that microglia expressing major histocompatibility complex (MHC) class II molecules are associated with the central nervous system (CNS) in aging and pathological conditions. In this study, we investigated the distribution of MHC class II-positive microglia in Parkinson's disease (PD) brains. The number of MHC class II-positive microglia in the substantia nigra (SN) and putamen increased as the neuronal degeneration of the SN proceeded. These cells were also ICAM-1 (CD54) and LFA-1 (CD11a) positive. The number of activated microglia not only in the SN and putamen but also in the hippocampus, transentorhinal cortex, cingulate cortex and temporal cortex in PD was significantly higher than that in the normal control. Most activated microglia persisted regardless of the presence or absence of Lewy bodies. They were frequently associated not only with α-synuclein-positive Lewy neurites, but also with TH-16-positive dopaminergic and WH-3-positive serotonergic neurites, as well as MAP-2- and SMI-32-positive neurites. These activated microglia were also positive for TNF-α and interleukin-6, which are known to have a neuroprotective function. We conclude that MHC class II-positive microglia are a sensitive index of neuropathological change and are actively associated with damaged neurons and neurites.

[1]  D. Walker,et al.  Microglia in degenerative neurological disease , 1993, Glia.

[2]  Kenji Kosaka,et al.  A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies , 2001, Journal of the Neurological Sciences.

[3]  Hugh Perry,et al.  The importance of ion channels for macrophage and microglial activation in vitro , 1998, Glia.

[4]  I. Mackenzie.  Activated microglia in dementia with Lewy bodies , 2000, Neurology.

[5]  H. Ichinose,et al.  Cytokines in Parkinson’s Disease , 2000 .

[6]  M. Mattson,et al.  Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Suzumura,et al.  Generation and characterization of monoclonal antibodies against rat microglia and ontogenic distribution of positive cells. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[8]  G. Kreutzberg,et al.  Regulation of thrombospondin in the regenerating mouse facial motor nucleus , 1996, Glia.

[9]  Kurt Jellinger,et al.  Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.

[10]  V. Perry.  A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation , 1998, Journal of Neuroimmunology.

[11]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[12]  R. Mohney,et al.  Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.

[13]  E. Hirsch,et al.  Caspase-8 Is an Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease, But Pathway Inhibition Results in Neuronal Necrosis , 2001, The Journal of Neuroscience.

[14]  M. Sakanaka,et al.  Neurons Induce the Activation of Microglial Cellsin Vitro , 1998, Experimental Neurology.

[15]  S. Styren,et al.  Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain , 1990, Experimental Neurology.

[16]  G. Kreutzberg.  Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[17]  T. Moos,et al.  The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease , 1999, Neuroscience.

[18]  D. Maysinger,et al.  The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: Congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury , 1995, International Journal of Developmental Neuroscience.

[19]  D. Dickson,et al.  Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. , 1990, The American journal of pathology.

[20]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[21]  J. Li,et al.  Free radicals in Parkinson's disease , 2002, Journal of Neurology.

[22]  Y. Agid,et al.  Nitric oxide synthase and neuronal vulnerability in parkinson's disease , 1996, Neuroscience.

[23]  Expression of HLA-DR and interleukin-2 receptor on reactive microglia in senile dementia of the alzheimer's type , 1987, Journal of Neuroimmunology.

[24]  Alexander Sasha Rabchevsky,et al.  Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth , 1997, Journal of neuroscience research.

[25]  E. Hirsch,et al.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Marunouchi,et al.  Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells , 1995, International Journal of Developmental Neuroscience.

[27]  T. Cai,et al.  Energetics of Leukocyte Integrin Activation (*) , 1995, The Journal of Biological Chemistry.

[28]  P. Mcgeer,et al.  Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR , 1987, Neuroscience Letters.

[29]  J. Houlé,et al.  Activated Macrophage/Microglial Cells Can Promote the Regeneration of Sensory Axons into the Injured Spinal Cord , 1997, Experimental Neurology.

[30]  D. Dickson,et al.  Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[31]  K. Beyreuther,et al.  A4 Protein in Alzheimer's Disease: Primary and Secondary Cellular Events in Extracellular Amyloid Deposition , 1989, Journal of neuropathology and experimental neurology.

[32]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[33]  K. Jellinger.  Cell death mechanisms in Parkinson's disease , 2000, Journal of Neural Transmission.

[34]  S. Appel,et al.  Immune reactivity in a mouse model of familial ALS correlates with disease progression , 2001, Neurology.

[35]  G. Kreutzberg,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the mouse facial motor nucleus after axonal injury and during regeneration , 1998, Journal of neurocytology.

[36]  M. Schwartz,et al.  Transplantation of activated macrophages overcomes central nervous system regrowth failure , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  I. Tooyama,et al.  Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders , 2004, Acta Neuropathologica.

[38]  M. Mattson,et al.  Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis , 1994, Neuron.

[39]  P. Blumbergs,et al.  Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. , 1995, Brain : a journal of neurology.

[40]  M. Farooque,et al.  Expression of ICAM-1 and CD11b after experimental spinal cord injury in rats. , 1999, Journal of neurotrauma.

[41]  M. Sakanaka,et al.  Microglial cells prevent nitric oxide‐induced neuronal apoptosis in vitro , 1998, Journal of neuroscience research.

[42]  A. Bruce-Keller.  Microglial–neuronal interactions in synaptic damage and recovery , 1999, Journal of neuroscience research.

[43]  S. Styren,et al.  Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.

[44]  L. Haverkamp,et al.  Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain , 1995, Neurochemistry International.

[45]  W. Hickey,et al.  Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.

[46]  P. Carvey,et al.  Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. , 2001, Experimental neurology.

[47]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[48]  K. Nagata,et al.  Plasminogen promotes the development of rat mesencephalic dopaminergic neurons in vitro. , 1993, Brain research. Developmental brain research.

[49]  Bin Liu,et al.  Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. , 2000, The Journal of pharmacology and experimental therapeutics.

[50]  J. Naegele,et al.  Activation of Microglia during Developmentally Regulated Cell Death in the Cerebral Cortex , 2000, Developmental Neuroscience.

[51]  V. Perry,et al.  Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain , 1985, Neuroscience.

[52]  Geoffrey A. Donnan,et al.  Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.

[53]  G. Kreutzberg,et al.  Cultured microglial cells have a distinct pattern of membrane channels different from peritoneal macrophages , 1990, Journal of neuroscience research.

[54]  C. Fall,et al.  Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.

[55]  P. Mcgeer,et al.  Expression of the histocompatibility glycoprotein HLA-DR in neurological disease , 2004, Acta Neuropathologica.

[56]  P. Carvey,et al.  Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons , 2001, Experimental Neurology.